Boehringer Ingelheim - March 2022 - case study 1
Start date:
Identification and optimisation of a risk stratified cohort of patients with Type 2 diabetes (T2D) across East Belfast Federation through the delivery of a pharmacist-led virtual and face to face service
Last modified: 29 May 2024
Last reviewed: 29 May 2024